drugset / Trial / NCT01027806

Effect of Montelukast Therapy in Obstructive Sleep Apnea(OSA) Children

NCT01027806

RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators leading hypotheses are: * Oral therapy with montelukast may lead to improved sleep study findings in children with mild to moderate Obstructive Sleep Apnea Syndrome (OSAS) who require surgical removal of adenoids and tonsils for OSAS. * A significant proportion of the children with OSAS treated with montelukast will show reduced severity of OSAS, and this will remove the need for surgical intervention.

Timeline

Start
2010-07
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified Oral